Morgan Stanley’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Morgan Stanley’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,050,317	Closed	-$427M	–	7260
2020 Q3	$427M	Buy	3,050,317 +2,180,193	+251%	+$266M	0.08%	216
2020 Q2	$65.4M	Buy	870,124 +45,270	+5%	+$2.37M	0.01%	717
2020 Q1	$23.5M	Buy	824,854 +328,577	+66%	+$8.51M	0.01%	1176
2019 Q4	$12.4M	Buy	496,277 +357,133	+257%	+$8.54M	﹤0.01%	2161
2019 Q3	$2.43M	Buy	+139,144	New	+$4.21M	﹤0.01%	3603

Morgan Stanley's LVGO Position: Q4 2020 in Review

Morgan Stanley sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 3,050,317 shares — an estimated $427M sold.

Morgan Stanley first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $427M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

Morgan Stanley reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Morgan Stanley sold 3,050,317 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $427M.
Morgan Stanley first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
Morgan Stanley's Livongo Health, Inc. Common Stock position peaked at $427M in Q3 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Morgan Stanley's 13F filing for Q4 2020, filed 16 Feb 2021.